{"_links": {"parentPackage": {"href": "/mdr/ct/packages/protocolct-2023-06-30", "title": "Protocol Controlled Terminology Package 54 Effective 2023-06-30", "type": "Terminology"}, "priorVersion": {"href": "/mdr/ct/packages/protocolct-2023-03-31/codelists/C197998", "title": "CDISC Protocol Substudy Attribute Terminology", "type": "Code List"}, "rootItem": {"href": "/mdr/root/ct/protocolct/codelists/C197998", "title": "Version-agnostic anchor resource for codelist C197998", "type": "Root Value Domain"}, "self": {"href": "/mdr/ct/packages/protocolct-2023-06-30/codelists/C197998", "title": "CDISC Protocol Substudy Attribute Terminology", "type": "Code List"}}, "conceptId": "C197998", "definition": "A terminology value set relevant to the attributes of the substudy entity.", "name": "Substudy Attribute Terminology", "preferredTerm": "CDISC Protocol Substudy Attribute Terminology", "submissionValue": "Substudy Attribute Terminology", "synonyms": ["Substudy Attribute Terminology"], "terms": [{"conceptId": "C165770", "definition": "A protocol designed for a parent study that provides the plan for coordinated conduct across the entirety of the study, with one or more substudies, which may have different objectives, to evaluate one or more investigational drugs and/or diseases within the overall trial structure. (FDA Guidance Document: Master Protocols: Efficient Clinical Trial Design Strategies to Expedite Development of Oncology Drugs and Biologics Guidance for Industry)", "preferredTerm": "Master Protocol", "submissionValue": "Master Protocol"}, {"conceptId": "C198229", "definition": "The protocol describing the formal plan of the substudy.", "preferredTerm": "Substudy Protocol", "submissionValue": "Substudy Protocol", "synonyms": ["Sub-Protocol"]}]}